Ashley Goland ’23 Immunotherapy is a form of cancer treatment that utilizes the body’s own immune system to destroy cancerous tumors and has shown promise in past animal and clinical human trials. For all of its dazzling successes to date, however, immunotherapy is not completely effective for treating the full range of cancer types and patients— yet. Scientists working in Sanofi Research and Development believe … Continue reading Trispecific Antibodies in Anticancer Immunotherapy
Gaurav Sharma ’22 Cancer immunotherapy has been extensively explored and requires information of the tumor’s antigen presentation in order for a method to be selected. An approach that is more effective and has a broader range had not been found that did not have the constraint of needing the information of the tumor’s antigen presentation. Researchers at Johns Hopkins School of Medicine and Johns Hopkins … Continue reading Nanoparticles May Be the New Future for Cancer Immunotherapy
Aditi Kaveti ’23 Peanut allergies affect 6% to 8% of children around the world. Living with severe allergies is extremely dangerous and requires close monitoring of the ingredients in packaged foods and at restaurants. Many packaged products warn that the food was manufactured in a facility that processes peanuts or tree nuts. These trace amounts seem inconsequential, but they can lead to severe allergic reactions. … Continue reading A Long-Term Solution for Individuals Living With Peanut Allergies
By Riya Gandhi ‘22 In recent years cancer therapy – especially cancer immunotherapy – has gained momentum and scientists’ interest has turned to immune checkpoint inhibitors (ICIs). ICIs aid in the suppression of checkpoint receptors to produce powerful immune responses against tumors. Although such a procedure is gaining momentum in clinical settings, much research must be done to legitimize this treatment for breast cancer. Under … Continue reading Inducing Tumor Cell Death by RIG-I: The Future of Breast Cancer?
By Riya Gandhi ‘22 Rather than look outwards for new cancer treatments, scientists are beginning to look inwards – that is, inside the human body – for advanced therapeutic treatments. Although the use of cytokines, biomolecules that direct an immune response,in cancer therapy has been attempted for decades, there is still room for much improvement. In a recent study on cytokines, researchers under the guidance … Continue reading In Situ Administration of Cytokine Combinations Could Be the Future of Immunotherapy
By Matthew Lee ‘21 Scientists and students alike are often well aware that one of the immune system’s most important roles is fighting cancer. In this effort, dendritic cells are especially important; particularly important are conventional type 1 dendritic cells (cDC1). Dendritic cells are a type of immune cell. cDCs can present tumor antigens to T cells and attract T cells via the secretion of … Continue reading Cellular regulation of tumorigenesis